Healio Gastroenterology Current Issue

The following articles appeared in the print edition of Healio Gastroenterology.

Table of Contents

• Endoscopic Therapies for GERD
• 9 Most Read EoE Stories of 2014
• Device for Non-Invasive Monitoring of Esophageal Disease, Inflammation in Development
• FDA Approves Generic Esomeprazole for GERD
• HCV Regimen Candidate Licensed by International Company
• Novel IBD Microbiome Drug Advanced to Phase 1 Trial
• Finding the 'Sweet Spot' for GERD Treatment
• Rapid Response from London 2014
• ASGE Warns Against Routine Antibiotic Prophylaxis Before GI Endoscopy
• Cytosponge Safe, Accurate Collection Method vs. Endoscopy for EoE
• Expansion of Genetic Testing Feasible for Familial CRC
• H. pylori Infection Associated with Reduced Risk for MS in Women
• Molecular Subtypes of CRC Associated with Differences in Patient Survival
• New Index Measures Progression of Crohn's Disease
• Novel Gene Mutations Associated with CRC in Black Patients Identified
• Sofosbuvir, Ribavirin Prevented Recurrent HCV Infection after Liver Transplant
• Split-Dose Bowel Cleansing Led to Fewer Intestinal Microbiota Changes
• Yeast-Consuming Gut Bacteria may Aid Development of Prebiotic Treatments
• Bevacizumab Plus FOLFOXIRI Extended Overall Survival in Advanced CRC
• High Vitamin D Levels Linked to Improved Outcomes in Metastatic Colorectal Cancer
• MM-398 Improved Outcomes in Metastatic Pancreatic Cancer
• Pembrolizumab Appears Safe, Effective in Advanced Gastric Cancer
• Ramucirumab Combination Benefited Patients with Advanced CRC
• Some Patients with Rectal Cancer may Safely Avoid Surgery
• BE Patients Prefer Endoscopic Intervention for Esophageal Adenocarcinoma
• Rapid Expansion of HCV Drugs, Treatment Population Signal Need for Cost Controls
• Surveyed Clinicians, Patients Prefer New Ostomy Device